CG
Chenna Gundala
About Chenna Gundala
Data last updated:
Chenna Gundala is a Director at Galoretx Pharmaceuticals Private Limited (since 2023) and Designated Partner at Peptis Pharma Llp (since 2021). The companies operate in Life Sciences and Research & Development. The largest current company by reported revenue is Galoretx Pharmaceuticals Private Limited at ₹2.52 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Galoretx Pharmaceuticals Private Limited U85320KA2018PTC114735 | Director | 06 Feb 2023 | 2018 | ₹2.52 Cr (FY 2024) | Active |
 Peptis Pharma Llp AAX-3868 | Designated Partner | 14 Jun 2021 | 2021 | Active |
Board colleagues of Chenna Gundala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Raghuveer Kallajhari Ramachandra | 08178693 | Galoretx Pharmaceuticals Private Limited | Whole-Time Director |
| Sasikumar Govindannair Pottayil | 09202031 | Galoretx Pharmaceuticals Private Limited , Peptis Pharma Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chenna Gundala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chenna Gundala
Chenna Gundala currently holds 2 directorships: Galoretx Pharmaceuticals Private Limited (Director, since 06 Feb 2023, revenue ₹2.52 Cr (FY 2024)); Peptis Pharma Llp (Designated Partner, since 14 Jun 2021).
Chenna Gundala was first appointed on 14 Jun 2021 as Designated Partner at Peptis Pharma Llp. The most recent appointment on record is 06 Feb 2023 at Galoretx Pharmaceuticals Private Limited.
The current boards of Chenna Gundala's companies include Raghuveer Kallajhari Ramachandra (Galoretx Pharmaceuticals Private Limited), Sasikumar Govindannair Pottayil (Galoretx Pharmaceuticals Private Limited).